The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.85
Bid: 32.85
Ask: 33.05
Change: 2.50 (8.24%)
Spread: 0.20 (0.609%)
Open: 30.90
High: 33.80
Low: 30.65
Prev. Close: 30.35
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 08:35

RNS Number : 7976F
Marston's PLC
06 March 2024

This announcement replaces RNS 6993F released on 05-03-2024 at 16:24 due to an amendment.

6 March 2024

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 4 March 2024 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 4 March 2024, being £0.2925 per ordinary share, save for the award granted to Hayleigh Lupino, where a notional share price of 33p was used to reflect the Remuneration Committee's decision to grant her an award over shares worth 125% of her base salary when the share price was 33p (which has decreased since that decision).

Awards under the Plan comprise two elements:

(i) a nil-cost option (a "Nil-Cost Option"), and

(ii) a CSOP Option over shares with a total value at the date of grant of £60,000 (the statutory limit) with an exercise price of £0.2925 per share (a "CSOP Option").

Performance Metrics

Nil-Cost Options will vest to the extent performance conditions are satisfied as set out below:

Measure

Weighting

Threshold (25% vest)

Maximum (100% vest)

Underlying PBT in 20261

20%

£75m

£95m

Net cash flow2 (2024, 2025 and 2026 aggregate)

40%

£150m

£180m

Operating Margin in 2026

20%

16.3%

18.3%

Relative Total Shareholder Return (TSR) (measured over FY2023/24 to FY2025/2026)

20%

Median

Upper quartile

1. Underlying PBT: exclusive of income from associates.

2. Net cash inflow/(outflow) as per the Net Debt note to the financial statements.

3. Straight-line vesting applies between Threshold and Maximum.

To the extent the performance metrics are met, a Nil-Cost Option will be released following the end of a further two-year holding period.

Linking Arrangement between Nil-Cost Option and CSOP Option

The options have been granted such that the maximum pre-tax value delivered to the participant will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal release date.

Name

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

205,128

2,871,795

Hayleigh Lupino

Director

205,128

1,347,041

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 7.375 pence each

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of awards under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.2925 per share and a nil-cost option.

c)

Price(s) and volumes(s)

Price

Volume

Nil-cost option: N/A

2,871,795

CSOP option: £0.2925

205,128

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

2024-03-04

f)

Place of the transaction

Outside a trading venue

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Hayleigh Lupino

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 7.375 pence each

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of awards under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.2925 per share and a nil-cost option.

c)

Price(s) and volumes(s)

Price

Volume

Nil-cost option: N/A

1,347,041

CSOP option: £0.2925

205,128

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

2024-03-04

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAPDKEDLLEEA
Date   Source Headline
16th Sep 201410:01 amRNSHolding(s) in Company
10th Sep 20149:21 amRNSHolding(s) in Company
9th Sep 20144:51 pmRNSHolding(s) in Company
5th Sep 20147:00 amRNSBoard Appointments
1st Sep 20144:41 pmRNSTotal Voting Rights
1st Aug 20142:52 pmRNSTotal Voting Rights
24th Jul 20147:00 amRNSInterim Management Statement
21st Jul 201412:13 pmRNSHolding(s) in Company
10th Jul 20143:06 pmRNSBlocklisting Interim Review
4th Jul 201410:57 amRNSTotal Voting Rights
1st Jul 20143:56 pmRNSTotal Voting Rights
26th Jun 20143:01 pmRNSDirector/PDMR Shareholding
25th Jun 20142:22 pmRNSHolding(s) in Company
25th Jun 20141:40 pmRNSDirector/PDMR Shareholding
18th Jun 201410:29 amRNSDirector/PDMR Shareholding
3rd Jun 20143:22 pmRNSTotal Voting Rights
19th May 20144:34 pmRNSDirector/PDMR Shareholding
15th May 20147:00 amRNSInterim Results
1st May 20141:12 pmRNSTotal Voting Rights
1st Apr 201411:23 amRNSTotal Voting Rights
3rd Mar 20142:06 pmRNSTotal Voting Rights
28th Feb 201412:22 pmRNSDirector/PDMR Shareholding
27th Feb 201411:40 amRNSHolding(s) in Company
3rd Feb 20143:50 pmRNSTotal Voting Rights
21st Jan 20144:16 pmRNSResult of AGM
21st Jan 20147:00 amRNSAGM and Interim Management Statement
13th Jan 201410:13 amRNSBlocklisting Interim Review
6th Jan 201411:45 amRNSHolding(s) in Company
2nd Jan 20143:47 pmRNSTotal Voting Rights
17th Dec 20134:37 pmRNSAnnual Financial Report
5th Dec 201310:09 amRNSDirector/PDMR Shareholding
2nd Dec 20134:14 pmRNSTotal Voting Rights
28th Nov 20137:00 amRNSNewRiver acquires portfolio for retail conversion
28th Nov 20137:00 amRNSDisposal of 202 pubs
28th Nov 20137:00 amRNSFinal Results
1st Nov 20133:33 pmRNSTotal Voting Rights
9th Oct 20137:00 amRNSYear-end Trading Statement
1st Oct 20132:42 pmRNSTotal Voting Rights
26th Sep 20133:55 pmRNSDirector/PDMR Shareholding
2nd Sep 201312:48 pmRNSTotal Voting Rights
1st Aug 201312:27 pmRNSTotal Voting Rights
25th Jul 20137:00 amRNSInterim Management Statement
10th Jul 20139:26 amRNSBlocklisting Interim Review
4th Jul 20132:51 pmRNSHolding(s) in Company
1st Jul 20134:24 pmRNSTotal Voting Rights
20th Jun 20132:41 pmRNSDirector/PDMR Shareholding
20th Jun 201310:42 amRNSDirector/PDMR Shareholding
6th Jun 20133:13 pmRNSHolding(s) in Company
3rd Jun 20139:49 amRNSTotal Voting Rights
17th May 201311:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.